AZITHROMYCIN FOR INJECTION, USP
HOSPIRA HEALTHCARE CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is AZITHROMYCIN FOR INJECTION, USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that AZITHROMYCIN FOR INJECTION, USP 500MG has been permanently discontinued (last updated March 28, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is AZITHROMYCIN FOR INJECTION, USP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ZITHROMAX CAP 250MG
PFIZER CANADA ULC
ZITHROMAX 600MG
PFIZER CANADA ULC
AZITHROMYCIN
PHARMASCIENCE INC
SANDOZ AZITHROMYCIN
SANDOZ CANADA INCORPORATED
PMS-AZITHROMYCIN
PHARMASCIENCE INC
PHL-AZITHROMYCIN
PHARMEL INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02334844
Strength
500MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Compare with another product →